Zepp Health (ZEPP) Fundamental Analysis: Revenue, Earnings & Valuation

7.92 / 10

Outperform

Fundamentals rate Outperform with a 7.9/10 quality score. Profit‑MV and Cash‑MV are strong, driving asset and revenue advantages. However, net profit margin and ROE are weak, dragging profitability metrics. Overall, the balance sheet and cash position are robust.

Analysis Checks(4/10)

Revenue-MV

Value0.29

Score3/3

Weight18.01%

1M Return14.71%

Annualized return on equity (%)

Value-17.19

Score1/3

Weight1.11%

1M Return1.25%

Profit-MV

Value0.68

Score2/3

Weight12.99%

1M Return11.68%

Rate of return on total assets (%)

Value-6.10

Score1/3

Weight1.31%

1M Return1.51%

Net profit margin (%)

Value-15.48

Score0/3

Weight-2.57%

1M Return-3.33%

Annualized return on total assets (%)

Value-6.10

Score1/3

Weight1.31%

1M Return1.51%

ROE (diluted) (%)

Value-18.68

Score0/3

Weight-2.90%

1M Return-3.58%

Asset-MV

Value-0.55

Score3/3

Weight58.11%

1M Return37.65%

Net profit / Total operating revenue (%)

Value-15.48

Score0/3

Weight-2.57%

1M Return-3.33%

Cash-MV

Value0.03

Score3/3

Weight15.20%

1M Return13.10%

Is ZEPP undervalued or overvalued?

ZEPP scores 7.92/10 on fundamentals and holds a Discounted valuation at present. Backed by its -17.15% ROE, -15.48% net margin, -3.91 P/E ratio, 0.73 P/B ratio, and 44.83% earnings growth, these metrics solidify its Outperform investment rating.